Seeing Is Believing
Currently out of the existing stock ratings of Matthew Harrison, 359 are a BUY (61.05%), 167 are a HOLD (28.4%), 62 are a SELL (10.54%).
Analyst Matthew Harrison works at MORGAN STANLEY with a stock forecast success ratio of 66.11% fulfilled within 188.06 days on average.
Matthew Harrison’s has documented 1,354 price targets and ratings displayed on 88 stocks. The coverage is on Healthcare, Technology, Basic Materials, Energy sectors.
Most recent stock forecast was given on GMAB, Genmab AS at 26-Mar-2024.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) at 2/23/2016. The price target of $5 was fulfilled within 1 day with a profit of $0.54 (12.11%) receiving and performance score of 121.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$3.8 (90.48%)
1 months 2 days ago
0/6 (0%)
$2.86 (55.64%)
Buy
9
$4.8 (114.29%)
3
1 months 8 days ago
1/7 (14.29%)
$4.18 (86.72%)
70
Sell
1
$-3.2 (-76.19%)
2
5 months 11 days ago
2/4 (50%)
$0.23 (29.87%)
30
Hold
5
7 months 18 days ago
1/2 (50%)
$-0.07 (-1.38%)
2
Buy
10
7 months 19 days ago
0/4 (0%)
$7.6 (316.67%)
Which stock is Matthew Harrison is most bullish on?
Which stock is Matthew Harrison is most reserved on?
What Year was the first public recommendation made by Matthew Harrison?